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Total knee Arthroplasty: risk factors for
allogeneic blood transfusions in the South
Asian population
Syed Hamza Mufarrih1*, Nada Qaisar Qureshi1, Arif Ali3, Azeem Tariq Malik1, Huda Naim2 and Shahryar Noordin3
Abstract
Background: Total knee arthroplasty (TKA) is the recommended treatment for end-stage knee osteoarthritis.
Considering the various risks associated with intra and postoperative blood transfusions, better understanding is
required with respect to the risk factors contributing to a greater possibility of blood transfusion during or after
surgery. Although literature highlights several such factors, our study is among the first to identify these risk factors
in the South Asian population which differs from other populations in several ways.
Methods: The study consists of a review of 658 patients undergoing TKA from 2005 to 2015. Data was obtained
from patient medical records and was analysed using logistic regression analysis. The relationship between each
predictor and the outcome variable was calculated as an Odds ratio (OR), the threshold of significance for which
was p = 0.25 and p = 0.05 for univariate and multivariable analysis respectively.
Results: The mean age of the patient population was 63 years (78% female), 25% of whom received one or more
blood transfusions. Multivariable analysis revealed 5 significant independent predictors for increased risk of blood
transfusions including bilateral knee surgery (OR:5.51), preoperative anemia (OR:4.15), higher ASA (American Society
of Anaesthesiologists) status (3–4) (OR:1.92), female sex (OR:3.44) and BMI (Body mass index) ≤30 (OR:1.79) while
increasing co-morbidities and age (>60) were found to be insignificant.
Conclusions: The factors identified for the South Asian population are largely similar to those for other populations.
Identification of high risk patients will permit the application of an international multipronged approach which not
only targets the modifiable risk factors but also the decision making process and blood management protocols in
order to minimize the transfusion associated risks for a patient undergoing a TKA.
Keywords: Blood transfusion, Total knee Arthroplasty, Risk factors
Background
Total Knee Arthroplasty (TKA) is the treatment of
choice for several end stage knee diseases. The aim of
the procedure is to relieve pain and restore the mobility
of the patient and has been proven to have excellent
results [1]. Intra and post-operative blood transfusions
increase the cost of surgery, not only directly but also
through the use of staff time and hospital resources and
prolonging hospital stay [2]. In developing countries, the
chance of acquiring blood borne infections is an added
risk associated with blood transfusions [3]. Previous
literature identifies, estimated blood loss, preoperative
anemia, bilateral procedures, advancing age, female sex,
higher ASA (American Society of Anesthesiologists)
status and low BMI (Body mass index) among others as
significant predictors for blood transfusions following
TKA [4–8]. To our knowledge, there has been no publi-
cation which assesses these risks in patients from South
Asia. The genetic variation between different ethnicities
has significant medical implications. The rationale for
this is population-specific mutations, linkage disequilib-
rium and different selecting pressures [9]. This leads to
the basis of unequal disease-associated and risk-associated
allele distribution in different populations which results in
discrete findings in different populations [9]. Similarly,
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literature highlights several other differences between
populations worldwide for instance lower anti-coagulant
requirements in Asian population suggests differences
in the coagulation factors between different ethnicities
[10–12] which would affect intra operative blood loss.
South Asia also has one of the highest rates of anemia
secondary to increased prevalence of carrier state of
haemoglobinopathies and micronutrient deficiencies
[13–17]. In addition to higher prevalence of anaemia,
studies have also shown that Asians have a higher
bleeding tendency [18]. While the rates of obesity in
many Asian countries are similar to those in USA, the
predisposition to developing obesity related non-
communicable diseases such as osteoarthritis is higher
is Asians [18, 19]. An important non-communicable
disease prevalent in Asians is diabetes which alters
haemostatic and thrombotic state of the body [20].
Along with this, ethnicity also plays a role when it
comes to sociocultural beliefs regarding lifestyle modifi-
cations including dietary habits and physical activity
along with poor accessibility to self-care facilities [21].
These factors, together with others such as a longer
mean operative duration make it imperative to study
blood transfusions intra and post-surgery in the Asian
population. The aim of our study was to identify the
factors which increase the risk of blood transfusions
during and after total knee arthroplasty surgery in the
South Asian population.
Methods
Study design and patient population
We conducted a retrospective review of the hospital
course of 658 patients who underwent Total Knee
Arthroplasty (TKA) between May 2005 and December
2015 at our University Hospital. All patients admitted
for an elective TKA with a primary diagnosis of ad-
vanced osteoarthritis or rheumatoid arthritis refractory
to conservative management were included in the study.
Patients undergoing revision arthroplasty or having
another orthopaedic procedure in addition to a TKA
during one anaesthetic session, as well as patients with
missing relevant clinical information were excluded from
the study. Unilateral surgeries and staged bilateral proce-
dures were included in the unilateral category while the
simultaneous bilateral procedure patients were included
in the bilateral category. Data was obtained from the
medical record files of all patients included in the study.
Data variables studied were patient demographics, body
mass index (BMI), concomitant co-morbidities including
Diabetes mellitus (DM), Hypertension (HTN), Asthma
and chronic obstructive pulmonary disease (COPD),
Thyroid Disease, Coronary artery disease (CAD), dyslipi-
daemia, Chronic kidney disease (CKD), preoperative and
postoperative haemoglobin levels, length of hospital stay,
type of anaesthesia, American Society of Anaesthesiol-
ogists (ASA) score, Anaesthesia and Operative time,
estimated intraoperative blood loss, and any intra and
post-operative blood transfusions received by the
patient.
Clinical course
Prior to the surgical procedure, every patient visited the
orthopaedic clinic where a thorough evaluation and all
preoperative investigations were done. The patients were
also preoperatively evaluated by anaesthesia and relevant
services depending on their co-morbidities in conjunction
with anaesthesia. Patients received routine postoperative
physiotherapy. Along with being vitally monitored, post-
operative day one measurements of blood haemoglobin
levels were requested to access the need for blood transfu-
sions. There are 8 major societies who have published
transfusion criteria. In general, the different guidelines
have recommended that transfusion is not indicated for
haemoglobin >10 g/dL, but the lower threshold varies
from 6 g/dL to 8 g/dL [22, 23]. In our setup, patients were
transfused blood after written consent, based on the cri-
teria of either experiencing persistent symptoms such as
dizziness, tachycardia, hypotension or shortness of breath
with a haemoglobin level of less than 9 g/dl or asymptom-
atic anaemia with a blood haemoglobin level of less than
7 g/dl. Discharge was based on the attainment of a stable
hemodynamic status and independent mobilization with
support.
Statistical analysis
Data analysis was performed using SPSS Version 22.
Descriptive analyses were conducted on all study mea-
sures, including patient characteristics and features of
their hospital stay, using measures of central tendency for
continuous measures and proportions for binary mea-
sures. Before stating central tendencies, normality test was
run on the data. For normally distributed data, mean was
used as the measure of central tendency while median was
used as the measure of central tendency for skewed data.
The relationship between blood transfusion as the out-
come variable with various predictors such as age, sex,
type of surgery, ASA, number of co-morbidities, obesity,
preoperative haemoglobin levels and operative time was
analysed by fitting a logistic regression model. The
outcome variable was treated as binary, by use of the
following categories: no transfusions versus 1 or more
transfusions. The threshold for statistical significance was
set at p = 0.25 for univariate analysis and p = 0.05 for mul-
tivariable analyses. The variables found to be insignificant
in univariate analysis were excluded from the multivari-
able analysis.
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Results
Patient characteristics and features of hospital stay
The mean age of the patient population was 62.5 years
with 78% female. Most patients had at least 1 but not
more than 2 comorbid conditions, with hypertension
and diabetes being the more prominent ones. The mean
BMI of the patients was 30.95, categorized as obese in
our study, supporting the well-established relationship
between obesity and development and progression of
osteoarthritis [24], which was also the most common
diagnosis of the patients selected for surgery. More pa-
tients underwent simultaneous bilateral TKA (58.7%) in
comparison to unilateral (41.3%) procedures. The mean
preoperative hemoglobin level was in the normal range
for females according to the cutoff value of >11, but was
low for males (cutoff > 13.6). The mean operative dur-
ation for unilateral and bilateral surgeries was 146 and
257 min respectively. The co-morbidities found preva-
lent were hypertension (58.2%), diabetes (28.1%) and
CAD (8.5%) among others. Most patients were diag-
nosed with Osteoarthritis (95.6%) while a small propor-
tion suffered from other diseases such Rheumatoid
arthritis (3.6%). The most common type of anesthesia
used was General (45.5%), followed by epidural com-
bined with general (34.4%) and epidural alone (20.1%).
Out of the 658 patients, 25% received blood transfu-
sions. Descriptive analysis for the above mentioned and
additional measures are given in Tables 1 and 2.
Effect of predictors on blood transfusions
The findings of our study have been tabulated in Table 3
as odds ratio (with 95% confidence interval) for univari-
ate analysis and adjusted odds ratio (with 95% confi-
dence interval) for multivariable analysis along with the
significance of each finding as a p-value, the threshold
for which is 0.25 for univariate analysis and 0.05 for
multivariable analysis. Univariate analysis shows 6 sig-
nificant variables for increased risk of blood transfu-
sions: bilateral surgery (OR: 4.34), preoperative anaemia
(OR: 2.20), higher ASA status (OR: 1.73), female gender
(OR: 1.59), BMI ≤30 (OR: 1.37) and increasing number
of co-morbidities (OR-1: 0.88, OR-2: 1.32, OR-3: 1.54,
OR-4: 5.44). The effect of advancing age on the outcome
variable was insignificant and was excluded from the
multivariable analysis. Multivariable analysis revealed 5
significant variables increasing blood transfusions: bilat-
eral surgery (OR: 5.51), preoperative anaemia (OR: 4.15),
higher ASA status (OR: 1.92), female gender (OR: 3.44)
and BMI ≤30 (OR: 1.79) while increasing number of co-
morbidities was deemed insignificant.
Discussion
Our study identified bilateral Total knee arthroplasty
surgery, preoperative anemia, the female sex, higher
ASA grade (3–4) and lower BMI (≤30) as independent
predictors for increased intra and post-operative blood
transfusions. However, advancing age (>60) did not
affect the outcome variable significantly. Increasing
number of co-morbidities, although not an independent
risk factor, also contributed to an increased risk of blood
transfusions. These findings are mainly similar to those
of previous studies done for other populations as dis-
cussed below except for the effect of increasing age. This
encourages the use of international practices regarding
blood loss and transfusion for the South Asian popula-
tion despite the differences in genetics and lifestyle in
comparison to other ethnicities.
Total Knee arthroplasty is now considered the gold
standard for the treatment of end stage osteoarthritis
[25]. With primary osteoarthritis being the most preva-
lent joint disease worldwide [26], it is crucial to study
the factors affecting the outcomes of this surgery. While
many studies have been done to study the long term
Table 1 Patient Characteristics (continuous variables)
Variable Central Tendency
Age (y) 62.5 ± 9.7
BMI (kg/m2) 30.47 ± 5.36
Pre-op Haemoglobin (g/dL)
Male 13.16 ± 1.43
Female 12.11 ± 1.27
Operative Duration (min)
Unilateral 143 ± 37
Bilateral 254 ± 56
Estimated Blood Loss (ml) 153 ± 124
Post-op Haemoglobin (g/dL)
Male 11.14 ± 1.39
Female 10.17 ± 1.34
Length of Stay (days) 9.00 ± 3
Table 2 Patient Characteristics (non-continuous variables)
Variable Categories Percentage (%)
Gender Male 21.9
Female 78.1
No. of co-morbidities 0 29.8
1–2 63.4
≥3 6.84
ASA Low risk (1–2) 77.5
High risk (3–4) 22.5
Type of Surgery Unilateral 41.3
Bilateral 58.7
Transfusions Received 25.1
Mufarrih et al. BMC Musculoskeletal Disorders  (2017) 18:359 Page 3 of 7
outcomes of total knee arthroplasty surgery in terms of
pain relief, restoration of mobility and overall quality of
life [27, 28], lesser data is available on the improvement of
the intra and postoperative course of the patient. Our
study targets one aspect of the latter by studying the fac-
tors contributing to an increased risk of blood transfusion
in patients undergoing Total Knee arthroplasty surgery.
Allogeneic blood transfusion can be a life-saving mo-
dality in the setting of acute blood loss as it is the fastest
way to increase blood hemoglobin levels. Even though
the process has evolved to much safer levels [29],
statistics show the occurrence of side effects in 10% of
the blood transfusions with 1/5000 transfusions suffering
from serious adverse reactions, including hemolytic
reactions, acute lung injury and multi organ failure sec-
ondary to bacterial contamination [30]. Additionally,
allogeneic blood transfusions have been associated with
an increased risk of complications including infections,
fluid overload and an increased length of stay at the
hospital [31, 32].
Our findings of simultaneous bilateral TKA being an
independent risk factor blood transfusions is consistent
with several findings in the past [2, 7, 33]. The greater
amounts of blood loss may be due to simultaneous bilat-
eral bone cuts and surgical trauma [5]. Research also
shows that the second knee in bilateral sequential TKAs
bleeds significantly more than the first one due to the hy-
pothesized decrease in clotting factors following release of
the first tourniquet and perioperative hypothermia as
suggested by animal models and in vitro studies [34].
However, even with the benefit of decreased risk of blood
transfusions in staged bilateral total knee arthroplasty
(BTKA) (categorized as unilateral TKA in our study),
there is evidence to suggest that the combined cost and
duration of hospital stay together with the doubled risk of
exposure to hospital environment and anesthesia for those
undergoing staged BTKA overcome the advantage of re-
quiring less blood transfusions. [35–38].
Results also revealed pre-operative hemoglobin to be a
significant risk factor for allogeneic blood transfusions.
These findings were consistent with numerous studies
done in the past which have identified pre-operative
hemoglobin as an independent risk factor for post-
operative blood transfusions. [7, 39–46]. Because patients
Table 3 Risk factors for allogeneic blood transfusions
Variable Odds Ratio (95% CI) Univariate analysis p-value Adjusted Odds Ratio (95% CI) Multivariate analysis p-value
Type of Surgery <0.001 <0.001
Unilateral 1 1
Bilateral 4.34 (2.81, 6.69) 5.51 (3.34, 9.01)
ASA 0.007 0.009
Low Risk (1–2) 1 1
High Risk (3–4) 1.73 (1.16, 2.58) 1.92 (1.18, 3.14)
Pre-op Haemoglobin <0.001 <0.001
Normal 1 1
Low 2.20 (1.52, 3.20) 4.15 (2.48, 6.96)
Sex 0.049 <0.001
Male 1 1
Female 1.59 (1.00, 2.52) 3.44 (1.84, 6.43)
BMI 0.098 0.008
> 30 (Obese) 1 1
≤ 30 (non-Obese) 1.37 (0.94, 2.00) 1.79 (1.17, 2.76)
No. of co-morbidities 0.048 0.379
None 1 1
1 0.88 (0.56, 1.38) 0.84 (0.49, 1.42)
2 1.32 (0.82, 2.12) 1.06 (0.60, 1.87)
3 1.54 (0.79, 2.99) 1.15 (0.51, 2.58)
4 5.44 (1.25, 23.61) 4.10 (0.81, 20.77)
Age 0.825
< 60 years 1
≥ 60 years 1.04 (0.72, 1.50)
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with low preoperative hemoglobin have a low reserve of
red blood cells that are further lowered after the surgical
procedure, they are at a higher risk of developing life-
threatening anemia and therefore require blood transfu-
sion to increase the hemoglobin level to an optimum level.
Given this, correction of preoperative anemia by stimulat-
ing erythropoiesis through administration of iron and
recombinant erythropoietin among other techniques has
also been suggested [47–49].
High-risk patients (ASA > 3) were also at a higher risk
of transfusions than low-risk (ASA 1–2) patients. Previous
studies have agreed with this finding [8, 31, 39, 41, 50, 51].
This may be due to the association of ASA levels 3 and 4
with greater number of co-morbidities and a greater
amount of intra operative blood loss [52].
Findings that females are at a higher risk of receiving
blood transfusions have been supported by previous
studies [2, 8]. Apart from the higher prevalence of iron
deficiency anemia in women [53], this could be due to
having the same cutoff value of 9 g/dl as the criteria for
blood transfusion for both sexes while having a normal
range of hemoglobin lower than that of men.
Even though most studies show no correlation be-
tween BMI and risk of blood transfusions [43–46, 54],
few studies have stated that a lower BMI (<30) serves as
an independent factor for increased risk of blood trans-
fusions in comparison to obese individuals who have lar-
ger volume and a lower percentage of estimated blood
loss (EBL) volume [39–42, 55]. Our findings agree with
this as the results show that a BMI ≤ 30 acts as an inde-
pendent factor for increased risk of blood transfusions.
Our study also identifies increasing number of comor-
bid conditions to increase the risk of blood transfusions,
although not independently. We did not find any studies
which have made the same comparison. Our findings
may be due the association of comorbid conditions with
higher ASA status which has been shown to be an inde-
pendent predictor for blood transfusions.
Previous studies have shown advancing age (>60) to be
a significant predictor of increased risk of blood transfu-
sions following TKA surgery [2, 7, 8, 45, 51]. Diminished
postoperative hematopoietic regenerative capacity second-
ary to advancing age could account for these findings [56].
Our findings do not demonstrate this relationship. This
may be due to the fact that the mean age of the population
being studied was 62.5 years, thus decreasing the sensitiv-
ity of our study to the effects of advancing age (≥60).
Having stated the risks associated with blood transfu-
sions and the factors contributing to increased chances
of receiving them, it is crucial to apply methods of min-
imizing their occurrence during the intra and postopera-
tive course of the patient’s experience. A multipronged
approach can be adopted to target not only the various
risk factors, but also the decision making process and
blood management protocols following identification of
high risk patients [57].
Caveats
As a single centre study, the number of patients studied is
not the true representation for the said population, which
is the primary focus of our study. To our knowledge, this
research is the first to study the South Asian population
which differs from other populations in several ways, as
discussed earlier. For greater accuracy and generalizability,
multi-centred studies should be carried out including hos-
pitals from several countries of South Asia.
Conclusions
Our study identifies simultaneous bilateral TKA surgery,
preoperative anaemia, higher ASA grade (3 and above),
female gender, and lower BMI (≤30) as independent pre-
dictors for an increased risk of blood transfusions during
and following knee arthroplasty surgery in South Asian
patients. These factors are similar to those for other
populations thus encouraging the use of international
guidelines for blood management protocols despite the
differences in the genetic makeup and lifestyle between
South Asians and other populations. This information
will help us in identification of high risk patients and
correction of modifiable risk factors to minimize the
need for blood transfusions in South Asian patients
undergoing TKA.
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